Elevance Health, Inc. (ELV)
Will Elevance Health (ELV) Beat Estimates Again in Its Next Earnings Report?
Elevance Health (ELV) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
California Public Employees Retirement System Raises Stock Position in Elevance Health, Inc. $ELV
California Public Employees Retirement System lifted its position in shares of Elevance Health, Inc. (NYSE: ELV) by 3.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 558,136 shares of the company's stock after acquiring an additional 19,153 shares during the
Elevance Health, Inc. $ELV Shares Sold by Alliancebernstein L.P.
Alliancebernstein L.P. trimmed its holdings in Elevance Health, Inc. (NYSE: ELV) by 34.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 913,051 shares of the company's stock after selling 482,748 shares during the period. Alliancebernstein L.P. owned about
Is the Options Market Predicting a Spike in Elevance Health Stock?
Investors need to pay close attention to ELV stock based on the movements in the options market lately.
Health Insurance Stock Could Rebound Off Historically Bullish Signal
Elevance Health Inc (NYSE:ELV) stock yesterday enjoyed its biggest single-day percentage gain since May 2024 after reporting $547 million in profits, but it wasn't enough to erase its worst day since March 2020 in the previous session, after the Centers for Medicare & Medicaid Services proposed to raise Medicare Advantage payment rates by only 0.09% in 2027.
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums
ELV tops Q4 EPS estimates as premiums grow and Carelon revenues surge, even as medical membership slips and expenses climb.
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain
Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inflation and higher utilization driving cost pressures and reduced profitability. Guidance for 2026 anticipates revenue and EPS declines, with adjusted EPS expected to drop 16% and investment income down 15%.
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Elevance Health (ELV) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Elevance Health (ELV) Beats Q4 Earnings Estimates
Elevance Health (ELV) came out with quarterly earnings of $3.33 per share, beating the Zacks Consensus Estimate of $3.1 per share. This compares to earnings of $3.84 per share a year ago.
Can Elevance Offset Rising Expenses in Q4 With Higher Premiums?
ELV heads into Q4 results with rising premiums and solid revenue growth, but higher expenses and margin pressure could weigh on earnings.
